AC AQUACELLE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

AC AQUACELLE Trademark

Serial Number: 79314441 • Registration: 6897520

AC AQUACELLE is a trademark filed by Pharmako Biotechnologies Pty Limited on April 23, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Pharmako Biotechnologies Pty Limited (13 trademarks)

2/2 Aquatic Dr

Entity Type: 82

Trademark Details

Filing Date

April 23, 2021

Registration Date

November 15, 2022

Published for Opposition

August 30, 2022

Goods & Services

Pharmaceutical products, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals all in the nature of pharmaceutical preparation for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceutical, cosmeceutical, and veterinary applications comprising tablets, gels, creams, oral suspension, irrigation solution, beverages, capsules, powdered preparations, liquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredients, namely, vitamin D, vitamin E, vitamin A, vitamin K, omega-3s and co-enzyme Q10, for the continuous release of a wide variety of therapeutic agents; nutritional preparations for medical use, namely, medications used for the delivery and absorption of nutrients being pharmaceutical products for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceutical, cosmeceutical, and veterinary applications comprising tablets, gels, creams, oral suspension, irrigation solution, beverages, capsules, powdered preparations, liquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredients, namely, vitamin D, vitamin E, vitamin A, vitamin K, omega-3s and co-enzyme Q10, for the continuous release of a wide variety of therapeutic agents; chemical products for use in medical or veterinary biotechnology, namely, chemical preparations for increasing bioavailability and absorption of active ingredients in foodstuffs and medicines, being pharmaceutical products for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for comprising tablets, gels, creams, oral suspension, irrigation solution, beverages, capsules, powdered preparations, liquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredients, namely, vitamin D, vitamin E, vitamin A, vitamin K, omega-3s and co-enzyme Q10, for the continuous release of a wide variety of therapeutic agents; medicated food additives being pharmaceutical products that facilitate or increase the absorption of vitamins and minerals, namely, pharmaceutical products for use as an ingredient in Self Micro-Emulsifying Drug Delivery System (SMEDDS) for nutraceutical, cosmeceutical, and veterinary applications comprising tablets, gels, creams, oral suspension, beverages, capsules, powdered preparations, liquid solutions and liquid preparations that increases the oral bioavailability and absorption of lipophilic active ingredients, namely, vitamin D, vitamin E, vitamin A, vitamin K, omega-3s and co-enzyme Q10, for the continuous release of a wide variety of therapeutic agents

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 29, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 8, 2023 FICS
FINAL DISPOSITION PROCESSED
Mar 8, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 15, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 15, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 15, 2022 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Sep 17, 2022 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 30, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 30, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 10, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 28, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 14, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 13, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 13, 2022 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 8, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 8, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 8, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 8, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 8, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 8, 2022 COAR
REFUSAL PROCESSED BY IB
Jan 30, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 13, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jan 13, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 22, 2021 RFCR
NON-FINAL ACTION WRITTEN
Dec 21, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 17, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 17, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 13, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 8, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 1, 2021 REPR